Skip to main content

Security report for ucb.com.mx

UCB de México S.A. de C.V. · Healthcare · Mexico

Low risk. 2 critical or high findings in Security headers and SSL/TLS.

Security score

76/100

Risk levelLow

0–100, higher is better. How it is calculated

UCB de México is a well-established biopharmaceutical company operating for 25 years in Mexico as part of the global UCB group. The company focuses on delivering innovative treatments in immunology and neurology, emphasizing patient care, sustainability, and gender equity. The website is professionally designed using Drupal CMS, with good mobile optimization and accessibility. Privacy and cookie policies are comprehensive and GDPR compliant, with active consent mechanisms. Security posture is strong with HTTPS, security headers, and no visible vulnerabilities, though explicit security policies and incident response contacts are not publicly provided. Overall, the site reflects a credible and trustworthy healthcare business with moderate to good digital maturity.

Scanned

NIS2 and GDPR posture

GDPR outside view
83/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

2 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching ucb.com.mx

This scan found 20 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
67
Security headers
65
Email security
60
DNS health
80
Network security
100
GDPR outside view
83
Average
76

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company holds a strong market position in Mexico's healthcare sector, leveraging its global parent company's legacy. Its business model centers on research, development, and commercialization of specialty medicines, supported by patient programs and sustainability initiatives. The website content targets patients, healthcare professionals, and employees, providing educational resources and corporate information. Partnerships with patient support sites and media outlets enhance its ecosystem. The absence of direct contact emails or phone numbers suggests a preference for controlled communication channels via contact forms.

Security posture

The website demonstrates a mature security posture with enforced HTTPS, modern security headers, and cookie consent aligned with privacy regulations. No critical vulnerabilities or exposed sensitive data were detected. However, the lack of a published security policy, incident response information, or vulnerability disclosure program limits transparency and readiness perception. The use of third-party analytics and consent management tools is appropriate but requires ongoing monitoring for security risks. Overall, the security posture is good but could be improved by adding explicit security governance documentation.

Recommendations

  1. Publish a dedicated security policy page outlining security practices and commitments.
  2. Provide clear incident response contact channels such as security@ or abuse@ emails.
  3. Implement and publish a vulnerability disclosure policy or security.txt file.
  4. Enhance contact information with verified company phone numbers and emails for support.
  5. Regularly review and update third-party scripts and analytics tools to mitigate risks.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
UCB de México S.A. de C.V.
Description
UCB de México is a global biopharmaceutical company delivering solutions that transform the lives of people living with severe diseases of the immune system or central nervous system. The company emphasizes sustainable work, patient care, employee well-being, gender equity, and access to medicines by 2030.
Key services
Immunology treatments, Neurology treatments, Established brands, Patient support programs
Content quality
good
Branding
consistent

Technology

Stack
Drupal CMS, JavaScript, Siteimprove Analytics, Google Tag Manager, OneTrust Cookie Consent
Frameworks
Drupal
Platforms
Web
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent with opt-in
  • No exposed sensitive data in HTML
  • Use of security headers

Analytics and tracking

Services
Siteimprove Analytics, Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Siteimprove Analytics
Marketing tools
OneTrust Cookie Consent
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is professionally designed and well-structured.
  2. Content is focused on healthcare, biopharmaceuticals, and patient support.
  3. Strong emphasis on sustainability, gender equity, and corporate responsibility.
  4. Comprehensive privacy and cookie policies with consent mechanisms.
  5. No direct company emails or phone numbers found on the main page; contact form is primary contact method.
  6. Use of modern analytics and cookie consent tools.
  7. No security policy or incident response information publicly available.
  8. No vulnerability disclosure or security.txt found.
  9. Social media presence is active and linked.
  10. No suspicious or malicious content detected.
Technical notes

Notes

The website is built on Drupal CMS with a modern tech stack including JavaScript, Google Tag Manager, and OneTrust for cookie consent. Performance is moderate with good mobile responsiveness and accessibility features. SEO is well addressed with proper meta tags and structured navigation. Hosting provider details are not explicit but the site uses HTTPS with strong SSL configuration. The site uses multiple external domains for analytics and social media integration, all reputable. Technical debt appears low, but continuous monitoring and updates are recommended to maintain security and performance.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with ucb.com.mx. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review ucb.com.mx.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.